Orikami is on a mission to improve 100 million lives before 2030 by enabling personalized healthcare

Orikami Contact

Orikami is a Dutch MedTech organization. We are specialized in applied data science. We develop and implement digital biomarkers to enable personalized healthcare for people with chronic diseases.

Our Mission

Our mission - to improve 100 million lives before 2030 by enabling personalized healthcare.

We believe health data is underutilized. We use real-world patient data to enable personalized healthcare paths for our clients to improve their quality of life. Therefore, we develop digital biomarkers.

Check out our services

VALUE of Digital Biomarkers

What are digital biomarkers?

Digital biomarkers are defined as objective, quantifiable physiological and behavioral data. They are collected and measured by means of digital devices such as portables, wearables, implantables or digestibles.

Clinical validated digital biomarkers provide objective data that provides clinically significant results. This enables decision support to clinicians and will optimize patients’ health paths.

Check out our academic approach

Awards

Clients and partners we work with

News

Orikami & Radboudumc, Department of Geriatrics

October 13, 2021 · 1 min read

Highlighted by the need for new, large-scale dementia-prevention and treatment trials, clinicians and researchers urgently need improved tools for remote monitoring of cognitive performance. Commonly used tests are not designed for frequent, remote testing in…

PROMPT – Freezing of Gait / Balance Digital Biomarker

August 18, 2021 · 1 min read

The activities listed below are made possible by the European Union. PROMPT (Personalised-care and Research On Motoric-dysfunctioning for Patient-specific Treatments) project receives a subsidy for the following activity(s): Development of an integrated system for the…

View all